UnitedHealth Group (NYSE:UNH) Stock Unloaded Rep. Richard McCormick

Key Points

• Rep. Richard McCormick sold $1,001–$15,000 of UnitedHealth Group stock on July 30 from his Growth Partners Roth IRA, along with similarly sized positions in 10 other companies.
• UnitedHealth reported quarterly EPS of $6.38, exceeding expectations of $4.94, while revenue reached $112.03 billion. The company reaffirmed fiscal 2026 EPS guidance of $19.50–$20.00 and declared a quarterly dividend of $2.32 per share.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $455.92, but lawsuits involving governance, cybersecurity and AI-driven claim denials present significant legal and reputational risks.

Representative Richard McCormick (Republican-Georgia) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on July 30th. The trade occurred in the Representative's "GROWTH PARTNERS ROTH IRA" account.

Representative Richard McCormick also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Medtronic NYSE: MDT on 7/30/2026.
• Sold $1,001 - $15,000 in shares of NextEra Energy NYSE: NEE on 7/30/2026.
• Sold $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 7/30/2026.
• Sold $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 7/30/2026.
• Sold $1,001 - $15,000 in shares of McDonald's NYSE: MCD on 7/30/2026.
• Sold $1,001 - $15,000 in shares of L3Harris Technologies NYSE: LHX on 7/30/2026.
• Sold $1,001 - $15,000 in shares of Johnson & Johnson NYSE: JNJ on 7/30/2026.
• Sold $1,001 - $15,000 in shares of Intercontinental Exchange NYSE: ICE on 7/30/2026.
• Sold $1,001 - $15,000 in shares of Illinois Tool Works NYSE: ITW on 7/30/2026.
• Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 7/30/2026.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $395.02 on Tuesday. The stock has a fifty day moving average price of $415.52 and a 200 day moving average price of $353.65. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The company has a market cap of $354.57 billion, a PE ratio of 25.42, a P/E/G ratio of 1.40 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. UnitedHealth Group's revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 19.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, September 14th. UnitedHealth Group's dividend payout ratio is 59.72%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth authorized a dividend, reinforcing shareholder returns and signaling confidence in its financial position. However, the announcement comes amid an ongoing governance lawsuit, which may limit its positive impact. UnitedHealth Group Authorizes Dividend Amid Governance Lawsuit
• Positive Sentiment: Wall Street’s average brokerage recommendation remains favorable, suggesting analysts believe UnitedHealth’s valuation and earnings outlook could support the shares. The bullish view is tempered by the tendency of sell-side recommendations to skew optimistic. Wall Street Bulls Look Optimistic About UnitedHealth
• Neutral Sentiment: The expected guilty plea by Luigi Mangione in the federal case involving the killing of UnitedHealthcare CEO Brian Thompson could bring additional clarity to a high-profile event, but it does not materially change UnitedHealth’s operating outlook. Luigi Mangione Reportedly Set to Plead Guilty
• Negative Sentiment: A shareholder lawsuit alleges UnitedHealth misled investors, failed to address governance and cybersecurity weaknesses, and discontinued an internal Medicare billing audit before the Change Healthcare cyberattack. The claims increase potential legal, regulatory and reputational risks. Investor Suit Says UnitedHealth Ignored Governance and Cybersecurity Gaps
• Negative Sentiment: A derivative lawsuit reportedly says executives knew that patients won roughly 90% of appeals against AI-generated claim denials. The allegation raises concerns about the accuracy of automated utilization management, potential compliance costs and damage to UnitedHealth’s reputation. UNH Patients Win 90% of AI Denial Appeals
• Negative Sentiment: An investor analysis argues that margin recovery is already reflected in UnitedHealth’s valuation, leaving future earnings growth as the next major test. This limits upside if revenue or membership growth disappoints. UnitedHealth Margin Recovery Is Priced In

Hedge Funds Weigh In On UnitedHealth Group

Several hedge funds have recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $25,000. Anfield Capital Management LLC grew its stake in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Joseph Group Capital Management purchased a new position in UnitedHealth Group during the 4th quarter valued at about $27,000. Nalls Sherbakoff Group LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $27,000. Finally, Lifetime Wealth Management P.C. purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $29,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on UNH shares. UBS Group raised their price objective on shares of UnitedHealth Group from $460.00 to $490.00 and gave the company a "buy" rating in a research report on Friday, July 17th. DA Davidson set a $512.00 target price on UnitedHealth Group in a research note on Tuesday, July 21st. Zacks Research upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 13th. Morgan Stanley increased their price objective on UnitedHealth Group from $468.00 to $529.00 and gave the stock an "overweight" rating in a research report on Friday, July 17th. Finally, Erste Group Bank upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Monday, April 27th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $455.92.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 500 shares of the firm's stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total transaction of $205,000.00. Following the completion of the transaction, the chief executive officer owned 16,497 shares of the company's stock, valued at approximately $6,763,770. This trade represents a 2.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.19% of the company's stock.

About Representative McCormick

Rich McCormick (Republican Party) is a member of the U.S. House, representing Georgia's 7th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. McCormick (Republican Party) is running for re-election to the U.S. House to represent Georgia's 7th Congressional District. He declared candidacy for the 2026 election. Rich McCormick lives in Suwanee, Georgia. McCormick served in the U.S. Marine Corps and the U.S. Navy. He earned an M.B.A. from National University and an M.D. from Morehouse School of Medicine. McCormick's career experience includes working as an emergency medicine physician with Gwinnett Medical Center and Northside Hospital, a Marine officer instructor with Georgia Tech and Morehouse College, and a pilot.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source